AURIGENE DISCOVERY TECHNOLOGIES LIMITED

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
C07D HETEROCYCLIC COMPOUNDS 21141
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 19236
 
  
 
C07K PEPTIDES 5131
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 2136
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 148
 
  
 
C07F ACYCLIC, CARBOCYCLIC, OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM, OR TELLURIUM 169
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 1166
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 1124
 
  
 
C40B COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES, IN SILICO LIBRARIES 121
 
  
 
G06F ELECTRIC DIGITAL DATA PROCESSING 1446

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0044,303 1,2,4-OXADIAZOLE AND THIADIAZOLE COMPOUNDS AS IMMUNOMODULATORSMar 07, 16Feb 15, 18[A61K, C07D, C07K]
2018/0044,304 1,3,4-OXADIAZOLE AND THIADIAZOLE COMPOUNDS AS IMMUNOMODULATORSMar 08, 16Feb 15, 18[A61K, C07D]
2018/0044,305 3-SUBSTITUTED 1,3,4-OXADIAZOLE AND THIADIAZOLE COMPOUNDS AS IMMUNOMODULATORSMar 10, 16Feb 15, 18[A61K, C07D]
2018/0044,329 3-SUBSTITUTED-1,2,4-OXADIAZOLE AND THIADIAZOLE COMPOUNDS AS IMMUNOMODULATORSMar 09, 16Feb 15, 18[A61K, C07D]
2018/0044,350 THERAPEUTIC CYCLIC COMPOUNDS AS IMMUNOMODULATORSMar 07, 16Feb 15, 18[A61K, C07D]
2017/0204,092 4,5-DIHYDROISOXAZOLE DERIVATIVES AS NAMPT INHIBITORSJul 22, 15Jul 20, 17[A61K, C07D]
2017/0152,263 Substituted Indazole Compounds as IRAK4 InhibitorsJun 19, 15Jun 01, 17[C07D]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9783578 Immunosuppression modulating compoundsDec 08, 14Oct 10, 17[A61K, C07K]
9776978 1,3,4-oxadiazole and 1,3,4-thiadiazole derivatives as immunomodulatorsOct 18, 16Oct 03, 17[A61K, C07D]
9732095 Bicyclic heterocyclyl derivatives as IRAK4 inhibitorsJan 12, 15Aug 15, 17[C07D]
9630932 Trisubstituted benzotriazole derivatives as dihydroorotate oxygenase inhibitorsFeb 24, 14Apr 25, 17[A61K, C07D]
9422339 Immunomodulating cyclic compoundsMar 28, 13Aug 23, 16[A61K, C07K]
9353107 3-(pyrazolyl)-1H-pyrrolo[2,3-b]pyridine derivatives as kinase inhibitorsJul 01, 13May 31, 16[A61K, C07D]
9233940 Cyclic peptidomimetic compounds as immunomodulatorsSep 05, 14Jan 12, 16[A61K, C07D]
9096642 Therapeutic compounds for immunomodulationDec 21, 11Aug 04, 15[A61K, C07K]
9062002 Substituted pyridine derivatives as FabI inhibitorsNov 29, 12Jun 23, 15[C07F, C07D]
9062075 Tetrahydropyridine derivatives as FabI inhibitorsJun 03, 14Jun 23, 15[A61K, C07D]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0088,822 Crystalline Structure of FABI from Burkholderia PseudomalleiAbandonedSep 30, 15Mar 30, 17[C12Q, C12N, C07D, G06F, C40B]
2016/0194,295 1,3,4-Oxadiazole and 1,3,4-Thiadiazole Derivatives as ImmunomodulatorsAbandonedSep 05, 14Jul 07, 16[A61K, C07D]
2016/0113,901 Cyclic Peptidomimetic Compounds as ImmunomodulatorsAbandonedJan 07, 16Apr 28, 16[A61K]
2015/0183,781 5-(1H-Pyrazol-4-yl)-1H-Pyrrolo[2,3-b]Pyridine Derivatives as Kinase InhibitorsAbandonedJul 25, 13Jul 02, 15[C07D]
2015/0073,024 1,2,4-Oxadiazole Derivatives as ImmunomodulatorsAbandonedSep 05, 14Mar 12, 15[A61K, C07D]
2014/0329,858 Cyclic Urea Derivatives As Androgen Receptor AntagonistsAbandonedDec 03, 12Nov 06, 14[C07D]
8440679 Bicyclic compounds and their uses as dual c-SRC / JAK inhibitorsExpiredFeb 17, 11May 14, 13[A61K, C07D, A61P]
2009/0149,504 Novel 5-Substituted Indole Derivatives As Dipeptidyl Peptidase IV (DPP-IV) InhibitorsAbandonedJun 15, 06Jun 11, 09[A61K, C07D]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.